In the news release, Inverness Medical Innovations, Inc. (Amex: IMA)Inverness Medical Innovations to Participate at Morgan Stanley GlobalHealthcare Unplugged Conference on April 30, 2008, issued earlier today byInverness Medical Innovations, Inc. over PR Newswire, we are advised by arepresentative of the company that the URL in the first paragraph wasinadvertently included and should be disregarded.
Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30, 2008
WALTHAM, Mass., April 25 /PRNewswire-FirstCall/ -- Inverness MedicalInnovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapiddiagnostic products for the consumer and professional markets, announced todaythat it will attend the upcoming Morgan Stanley Global Healthcare UnpluggedConference being held April 30 - May 2, 2008, at the Ritz-Carlton Key Biscaynein Florida. Ron Zwanziger, Chief Executive Officer, will attend. Hispresentation is scheduled for Wednesday, April 30th at 2:20 p.m.(https://events.jpmorgan.com/) During his presentation, Mr. Zwanziger maydiscuss and answer questions concerning business and financial developmentsand trends. His response to questions, as well as other matters discussed, maycontain or constitute information that has not been disclosed previously.
By developing new capabilities in near-patient diagnosis, monitoring andhealth management, Inverness Medical Innovations enables individuals to takecharge of improving their health and quality of life. A global leader inrapid point-of-care diagnostics, Inverness' products, as well as its newproduct development efforts, focus on infectious disease, cardiology,oncology, drugs of abuse and women's health. Inverness is headquartered inWaltham, Massachusetts.
SOURCE Inverness Medical Innovations, Inc.